Talent
McMaster University biochemistry student Suky Zheng attended OICR’s 2024 Translational Research conference and was inspired by the people she met and their efforts to help people affected by cancer. It has been said that if…
OICR News / Tag
Immuno-oncology
TAG ARCHIVE
Browse news tagged Immuno-oncology.
More stories
Tagged stories
Technology
OICR President and Scientific Director Dr. Laszlo Radvanyi reflects on the potential impact of a novel drug for metastatic melanoma, and his important role in the drug’s development. The U.S. Food and Drug Administration (FDA)…
TechnologyBreast cancer
Dr. Sam Workenhe. (University of Guelph) Researchers at the University of Guelph and McMaster University create combination immunotherapy approach to treat breast tumours and other cancers Over the last few decades, scientists have made significant…
Cancer solved together — in your inbox
The latest findings, funding, and partnerships from Ontario’s cancer research institute. Briefings and deeper dives.
Subscribe
TechnologyClinical trials
In the race to find new ways to prevent and treat COVID-19, OICR-supported researchers have launched an innovative clinical trial focussed on strengthening the immune system for one of the most vulnerable populations – cancer…
TechnologyTreatment
Drs. Yonghong Wan and Scott Walsh McMaster University researchers validate a new treatment approach that could help bring the benefits of Adoptive T-cell therapies to patients with solid tumours Adoptive T-cell therapy (ACT) is an…
Talent
OICR is proud to announce two new partnerships between research trainees in Ontario and collaborators in Israel, supported by Joseph and Wolf Lebovic. The Joseph and Wolf Lebovic Fellowship Program, a joint initiative between the…